| Serial Number | 79410484 |
| Word Mark | FAVRE-LEUBA |
| Filing Date | Thursday, October 17, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, September 12, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | FAVRE LEUBA |
| Goods and Services | Timepieces; watches; watch movements and their spare parts; watch cases being parts of watches |
| International Class | 014 - Precious metals and their alloys and goods in precious metals or coated therewith, not included in other classes; jewelry, precious stones; horological and chronometric instruments. |
| US Class Codes | 002, 027, 028, 050 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 21, 2024 |
| Primary Code | 014 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SILVERCITY BRANDS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Event Date | Event Description |
| Thursday, November 21, 2024 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Monday, November 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 25, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, June 5, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, June 20, 2025 | REFUSAL PROCESSED BY IB |
| Monday, March 24, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, April 1, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 2, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, June 5, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, September 11, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 11, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 11, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 12, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |